Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

EJMCR. 2022; 6(9): 160-164


A rare case of fibrous pseudotumor of the epididymis treated with testis-sparing surgery

Luca Topazio, Federico Romantini, Daniela Biferi, Federico Narcisi, Francesco Chiaramonti, Pietro Morgia.




Abstract
Cited by 0 Articles

Background: Paratesticular fibrous pseudotumors are rare benignant intrascrotal lesions that can often mimic malignancy. They often arise in the scrotal tunic while less common localizations are the epididymis and the spermatic cord. Their diagnosis is challenging and often done post-operatively on definitive histopathology; for this reason, they are often treated with orchiectomy which results in overtreatment.
Case Presentation: We present a case of a 42-year-old male patient that came to our observation for scrotal swelling. Physical exam and ultrasound showed a healthy testis but multiple painless, tender, oval lesions at the level of the epididymis. Laboratory tests and testicular markers were within normal limits, thus we planned explorative surgery with frozen sections that excluded malignancy. We performed testis-sparing surgery with epididymectomy, vasectomy, and resection of the tunica vaginalis. Definitive histopathology revealed a fibrous pseudotumor. To date, at 3 months follow-up, the patient is in good clinical condition with no signs of recurrence and with healthy homolateral testis.
Conclusion: Fibrous pseudotumor can mimic malignancy. A correct diagnosis is pivotal to choosing the correct treatment and avoiding aggressive surgery.

Key words: Benign testicular neoplasm, paratesticular fibrous pseudo-tumor, benign fibrous paratesticular tumor, testis-sparing treatment. inflammatory pseudotumor.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.